EDITORIALS
95 Growing Up: Evolving Concepts of Adult Attention De fi cit Hyperactivity Disorder
Philip Shaw
97 Antisuicidal Effects of Ketamine: A Promising First Step
Madhukar H. Trivedi
99 Why Apathy in Alzheimer’s Matters
David L. Sultzer
101 Optimizing the Pharmacologic Treatment of Individuals With First-Episode Psychosis Donald C. Goff
TREATMENT IN PSYCHIATRY
103 Prolonged Postconcussive Symptoms
Davin K. Quinn, et al.
PERSPECTIVES IN GLOBAL MENTAL HEALTH
112 The “Loss of Pride” Syndrome in Yazidi Refugees
Rami Bou Khalil, et al.
REVIEWS AND OVERVIEWS
114 The Neurodevelopmental Basis of Early Childhood Disruptive Behavior: Irritable and
Callous Phenotypes as Exemplars Lauren S. Wakschlag, et al.
ARTICLES
131 Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial
Dorothy K. Sit, et al.
140 Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25
Margaret H. Sibley, et al.
150 The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson, et al
159 Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer’s Disease: A Double-Blind,Randomized, Placebo-Controlled Trial
Prasad R. Padala, et al.
169 Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention
Delbert G. Robinson, et al.
180 Cortical Functional Connectivity Evident After Birth and Behavioral Inhibition at Age 2
Chad M. Sylvester, et al.
LETTERS TO THE EDITOR
188 The Impact of Underpowered Studies on Clinical Trial Results
Arif Khan, et al.
188 The Importance of Adequately Powered Clinical Studies: Response to Khan et al.
Stephen R. Marder, et al.
189 Pharmacogenetic Tests in Psychiatry
Chad Bousman, et al.
BOOK FORUM
190 The Psychoses of Menstruation and Childbearing
191 Public Health Perspectives on Depressive Disorders